Comparison of epichlorohydrin-dimethylamine with other cationic organic polymers as coagulation aids of polyferric chloride in coagulation-ultrafiltration process

Journal of Hazardous Materials
Shenglei SunWuchang Song

Abstract

Epichlorohydrin-dimethylamine (DAM-ECH) copolymer was acquired by polycondensation of hazardous reagents: epichlorohydrin (analytical reagent, A.R.) and dimethylamine (A.R.) with ethanediamine (A.R.) as cross-linker. Its coagulation and membrane performance as coagulation aid of polyferric chloride (PFC) was evaluated by comparing with other two cationic coagulation aids: poly dimethyl diallyl ammonium chloride (PDMDAAC) and polyacrylamide (PAM) in humic acid-kaolin (HA-Kaolin) simulated water treatment. Firstly, optimum dosages of PFC&DAM-ECH, PFC&PDMDAAC and PFC&PAM were identified according to their coagulation performance. Then their impacts (under optimum dosages) on membrane fouling of regenerated cellulose (RC) ultra-membrane disc in coagulation-ultrafiltration (C-UF) process were reviewed. Results revealed that small addition of DAM-ECH was the effective on turbidity and DOC removal polymer. Furthermore, in the following ultra-filtration process, external membrane fouling resistance was demonstrated to be the dominant portion of the total membrane fouling resistance under all circumstances. Meanwhile, the internal membrane fouling resistance was determined by residual of micro-particles(1) that cannot be intercepted by ...Continue Reading

References

Mar 20, 2001·Journal of Colloid and Interface Science·Cordelia SelomulyaT. David Waite
Sep 8, 2001·Water Research·X Y Li, B E Logan
Jul 8, 2005·Water Research·P JarvisS A Parsons
Sep 30, 2005·Environmental Science & Technology·Sangyun A LeeT David Waite
Sep 25, 2007·Water Research·Teresa SerraBruce E Logan
Apr 15, 2008·Water Research·David R Simpson
Nov 16, 2010·Journal of Animal Physiology and Animal Nutrition·A V VucskitsJ Szabó

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.